Gyre Therapeutics, Inc. (GYRE)
7.87
-0.59
(-6.97%)
USD |
NASDAQ |
Dec 11, 16:00
7.865
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics Total Assets (Quarterly): 159.38M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 568.69M |
| Savara, Inc. | 140.92M |
| Exelixis, Inc. | 2.824B |
| Vanda Pharmaceuticals, Inc. | 601.14M |
| Aldeyra Therapeutics, Inc. | 77.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.97M |
| Shareholders Equity (Quarterly) | 101.92M |
| Debt to Equity Ratio | 0.0114 |
| Current Ratio | 6.195 |
| Net Debt Paydown Yield | 0.02% |